Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study

Viecelli AK 1 , Pascoe EM 2 , Polkinghorne KR 3 , Hawley CM 1 , Paul-Brent PA 2 , Badve SV 2 Show all authors , Cass A 4 , Johnson DW 1 , Kerr PG 3 , Mori TA 5 , Scaria A 2 , Hooi LS 6 , Ong LM 7 , Irish AB 5 , FAVOURED study team

Affiliations 

  • 1 Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
  • 2 Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, Queensland, Australia
  • 3 Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, Australia
  • 4 Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia
  • 5 School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia
  • 6 Department of Medicine and Haemodialysis Unit, Hospital Sultanah Aminah, Johor Bahru, Malaysia
  • 7 Department of Nephrology, Penang Hospital, George Town, Malaysia
Nephrology (Carlton), 2017 10;22(10):823-824.
PMID: 27188542 DOI: 10.1111/nep.12823

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications